# OnCo record nct06126510 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06126510/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06126510", "NCT06126510" ;
  schema:name "Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma"@en ;
  schema:description "A phase 2 trial of Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell) in sarcomas, run by CNBG-Virogin Biotech (Shanghai) Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06126510/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06126510> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-07-18" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> .